PSUSA/00002486/202603
PSUSA/00002486/202603
PSUSA/00002486/202603
PSUSA/00009277/202603
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26 - 29 October 2026
Referral: Flupentixol/melitracen-containing medicinal products, flupentixol,melitracen, associated names: Deanxit Article 31 referrals Procedure started
Reporting suspected side effects
Executive decision the contribution to travel and subsistence expenses for the candidate invited to attend a selection procedure
PSUSA/00011098/202602
PSUSA/00000907/202603
PSUSA/00001316/202603
21st industry stakeholder platform - operation of European Union (EU) pharmacovigilance, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 October 2026, 13:00 (CEST) to 20 October 2026, 17:30 (CEST)